Nusano

36:11

The Goldilocks Isotope? Why Astatine-211 Might Be Just Right for Radiotherapeutics

38:34

Episode 8, Luke Nordquist, CEO of XCancer

31:59

Episode 7, Matt Furlow, Assoc. Principal & Head of Radiopharmaceutical Center of Excellence at ZS

1:25

We're buzzing about this! Nusano named Researcher of the Year at BioHive Awards

0:55

Do we have enough people to support the radiopharmaceuticals boom? #podcast

0:36

Targeting cancers in the early stages #podcast #talkradioisotopes

32:37

Episode 6, Suzanne Lapi, Cyclotron Facility Director at the University of Alabama at Birmingham

0:36

Talking radiopharmaceutical realities with Dr. Shamar Young #podcast #radioisotopes #oncology

32:15

Episode 5 - Shamar Young, Chief Medical Officer at TeleDaaS

1:25

Nusano Named Researcher of the Year at 2025 Best of BioHive Awards

0:32

Radiopharmaceuticals market in next five years #podcast #talkradioisotopes

42:01

Episode 4 - Bruno Paquin, CEO of AtomVie Global Radiopharma

31:32

Episode 3 - Arjun Murthy, Co-Founder of Maven Bio

46:34

Episode 2 - Shaemus Gleason, Executive Vice President at Clarity Pharmaceuticals

38:57

Episode 1 - Jeff Jones, Managing Director, Senior Analyst at Oppenheimer & Company

1:14

Trailer - Talk Radioisotopes: Going Nuclear on Cancer

1:05:46

Office Hours: Radiopharmaceuticals - Presented by Nusano

1:13:11

Webinar: Emerging Trends in Radiotherapeutics

1:20:58

Webinar: Unlocking the Next $20-30B Opportunity in Oncology: Radioisotope Production & Applications

2:14

Technical Overview: How the Nusano Ion Source Creates Alpha Ions

1:35

Nusano Beam Flythrough

3:31

Transforming Medical Radioisotope Production: The Nusano Platform

1:33

Transforming Medical Radioisotope Production: The Nusano Platform (Short Version)

0:23

Nusano West Valley City Production Site

1:35

Nusano: Supplying the Fight Against Cancer